BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25691538)

  • 41.
    Makarawate P; Chaosuwannakit N; Vannaprasaht S; Sahasthas D; Koo SH; Lee EJD; Tassaneeyakul W; Barajas-Martinez H; Hu D; Sawanyawisuth K
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28584071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validation and Disease Risk Assessment of Previously Reported Genome-Wide Genetic Variants Associated With Brugada Syndrome: SADS-TW BrS Registry.
    Jimmy Juang JM; Liu YB; Julius Chen CY; Yu QY; Chattopadhyay A; Lin LY; Chen WJ; Yu CC; Huang HC; Ho LT; Lai LP; Hwang JJ; Lin TT; Liao MT; Chen JJ; Sherri Yeh SF; Chuang JY; Yang DH; Lin JL; Lu TP; Chuang EY; Ackerman MJ
    Circ Genom Precis Med; 2020 Aug; 13(4):e002797. PubMed ID: 32490690
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel
    Monasky MM; Micaglio E; Ciconte G; Rivolta I; Borrelli V; Ghiroldi A; D'Imperio S; Binda A; Melgari D; Benedetti S; Mitrovic P; Anastasia L; Mecarocci V; Ćalović Ž; Casari G; Pappone C
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A balanced translocation disrupting SCN5A in a family with Brugada syndrome and sudden cardiac death.
    Yeates L; Ingles J; Gray B; Singarayar S; Sy RW; Semsarian C; Bagnall RD
    Heart Rhythm; 2019 Feb; 16(2):231-238. PubMed ID: 30170230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Common SCN10A variants modulate PR interval and heart rate response during atrial fibrillation.
    Delaney JT; Muhammad R; Shi Y; Schildcrout JS; Blair M; Short L; Roden DM; Darbar D
    Europace; 2014 Apr; 16(4):485-90. PubMed ID: 24072447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In silico validation revealed the role of SCN5A mutations and their genotype-phenotype correlations in Brugada syndrome.
    Pham HM; Nguyen DP; Ta TD; Le TP; Phan PH; Trinh HA; Tran TV; Luong TLA; Nguyen HM; Bui TH; Tran TH; Ta TV; Tran VK
    Mol Genet Genomic Med; 2023 Dec; 11(12):e2263. PubMed ID: 37547970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.
    Hu D; Barajas-Martínez H; Medeiros-Domingo A; Crotti L; Veltmann C; Schimpf R; Urrutia J; Alday A; Casis O; Pfeiffer R; Burashnikov E; Caceres G; Tester DJ; Wolpert C; Borggrefe M; Schwartz P; Ackerman MJ; Antzelevitch C
    Heart Rhythm; 2012 May; 9(5):760-9. PubMed ID: 22155597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.
    Kapplinger JD; Tester DJ; Alders M; Benito B; Berthet M; Brugada J; Brugada P; Fressart V; Guerchicoff A; Harris-Kerr C; Kamakura S; Kyndt F; Koopmann TT; Miyamoto Y; Pfeiffer R; Pollevick GD; Probst V; Zumhagen S; Vatta M; Towbin JA; Shimizu W; Schulze-Bahr E; Antzelevitch C; Salisbury BA; Guicheney P; Wilde AA; Brugada R; Schott JJ; Ackerman MJ
    Heart Rhythm; 2010 Jan; 7(1):33-46. PubMed ID: 20129283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of SCN5A coding and non-coding sequences in Brugada syndrome onset: What's behind the scenes?
    Daimi H; Khelil AH; Neji A; Ben Hamda K; Maaoui S; Aranega A; Be Chibani J; Franco D
    Biomed J; 2019 Aug; 42(4):252-260. PubMed ID: 31627867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disease-targeted sequencing of ion channel genes identifies de novo mutations in patients with non-familial Brugada syndrome.
    Juang JM; Lu TP; Lai LC; Ho CC; Liu YB; Tsai CT; Lin LY; Yu CC; Chen WJ; Chiang FT; Yeh SF; Lai LP; Chuang EY; Lin JL
    Sci Rep; 2014 Oct; 4():6733. PubMed ID: 25339316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations.
    Béziau DM; Barc J; O'Hara T; Le Gloan L; Amarouch MY; Solnon A; Pavin D; Lecointe S; Bouillet P; Gourraud JB; Guicheney P; Denjoy I; Redon R; Mabo P; le Marec H; Loussouarn G; Kyndt F; Schott JJ; Probst V; Baró I
    Basic Res Cardiol; 2014; 109(6):446. PubMed ID: 25341504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutational analysis of mitochondrial DNA in Brugada syndrome.
    Stocchi L; Polidori E; Potenza L; Rocchi MB; Calcabrini C; Busacca P; Capalbo M; Potenza D; Amati F; Mango R; Romeo F; Novelli G; Stocchi V
    Cardiovasc Pathol; 2016; 25(1):47-54. PubMed ID: 26549652
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of a SCN5A founder mutation causing sudden death, Brugada syndrome, and conduction blocks in Southern Italy.
    Curcio A; Malovini A; Mazzanti A; Memmi M; Gambelli P; La Rosa F; Bloise R; Indolfi C; Bellazzi R; Napolitano C
    Heart Rhythm; 2021 Oct; 18(10):1698-1706. PubMed ID: 34245912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systematic re-evaluation of SCN5A variants associated with Brugada syndrome.
    Denham NC; Pearman CM; Ding WY; Waktare J; Gupta D; Snowdon R; Hall M; Cooper R; Modi S; Todd D; Mahida S
    J Cardiovasc Electrophysiol; 2019 Jan; 30(1):118-127. PubMed ID: 30203441
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel
    Micaglio E; Monasky MM; Resta N; Bagnulo R; Ciconte G; Giannelli L; Locati ET; Vicedomini G; Borrelli V; Ghiroldi A; Anastasia L; Benedetti S; Di Resta C; Ferrari M; Pappone C
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Copy number variations of SCN5A in Brugada syndrome.
    Sonoda K; Ohno S; Ozawa J; Hayano M; Hattori T; Kobori A; Yahata M; Aburadani I; Watanabe S; Matsumoto Y; Makiyama T; Horie M
    Heart Rhythm; 2018 Aug; 15(8):1179-1188. PubMed ID: 29574140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death.
    Juang JJ; Binda A; Lee SJ; Hwang JJ; Chen WJ; Liu YB; Lin LY; Yu CC; Ho LT; Huang HC; Chen CJ; Lu TP; Lai LC; Yeh SS; Lai LP; Chuang EY; Rivolta I; Antzelevitch C
    EBioMedicine; 2020 Jul; 57():102843. PubMed ID: 32645615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Whole exome sequencing in Brugada and long QT syndromes revealed novel rare and potential pathogenic mutations related to the dysfunction of the cardiac sodium channel.
    Chen J; Li H; Guo S; Yang Z; Sun S; Zeng J; Gou H; Chen Y; Wang F; Lin Y; Huang K; Yue H; Ma Y; Lin Y
    Orphanet J Rare Dis; 2022 Oct; 17(1):394. PubMed ID: 36303204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel microsatellite polymorphism of sodium channel beta1-subunit gene (SCN1B) may underlie abnormal cardiac excitation manifested by coved-type ST-elevation compatible with Brugada syndrome in Japanese.
    Ogawa R; Kishi R; Takagi A; Sakaue I; Takahashi H; Matsumoto N; Masuhara K; Nakazawa K; Kobayashi S; Miyake F; Echizen H
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):109-19. PubMed ID: 20137763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brugada syndrome risk loci seem protective against atrial fibrillation.
    Andreasen L; Nielsen JB; Darkner S; Christophersen IE; Jabbari J; Refsgaard L; Thiis JJ; Sajadieh A; Tveit A; Haunsø S; Svendsen JH; Schmitt N; Olesen MS
    Eur J Hum Genet; 2014 Dec; 22(12):1357-61. PubMed ID: 24667784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.